LevelJump Announces Strategic $1.5 Million Financing
LevelJump Healthcare (TSXV: JUMP) this morning announced that it will be conducting a non-brokered private placement. The financing will look to raise gross proceeds of up to $1.5 million.
Under the terms of the financing, the company intends to sell 10.0 million units at a price of $0.15 per unit. Each unit is to contain one common share and one common share purchase warrant. Each warrant is valid for a period of three years from the date of issuance at a price of $0.20 per share.
Proceeds from the financing are to be used for acquisitions as well as general working capital.
The company has indicated that the intention of the financing is to include strategic investors, comprised of both high net worth investors as well as private investment funds whom will support the long term vision of the company.
The financing is expected to close in early May 2021.
LevelJump Healthcare last traded at $0.22 on the TSX Venture.
FULL DISCLOSURE: Leveljump Healthcare Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Leveljump Healthcare Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.